User:ScottYoung: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Larry Sanger
("CZ Live" is used only for articles, not for user pages)
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{AccountNotLive}}
W. Scott Young, M.D., Ph.D.  
W. Scott Young, M.D., Ph.D.  
Dr. Young received his B.A., M.D., and Ph.D from The Johns Hopkins University. The latter degree, obtained under the guidance of Michael Kuhar, described the development of in vitro receptor autoradiography and the first applications of the technique to the localization of neurotranmsitter receptors in human and other animal brains. Dr. Young then completed an internship in internal medicine at the University of Maryland and a residency in neurology at the University of Virginia. He joined the National Institute of Mental Health in 1984 where he is a Senior Investigator ( http://neuroscience.nih.gov/Lab.asp?Org_ID=167 ) who has studied the expression of vasopressin and oxytocin in the hypothalamic paraventricular and supraoptic nuclei. Dr. Young's laboratory is currently creating and using knock-out and transgenic mice to study the roles of vasopressin and oxytocin in the brain.
Dr. Young received his B.A., M.D., and Ph.D from The Johns Hopkins University. The latter degree, obtained under the guidance of Michael Kuhar, described the development of in vitro receptor autoradiography and the first applications of the technique to the localization of neurotranmsitter receptors in human and other animal brains. Dr. Young then completed an internship in internal medicine at the University of Maryland and a residency in neurology at the University of Virginia. He joined the National Institute of Mental Health in 1984 where he is a Senior Investigator ( http://neuroscience.nih.gov/Lab.asp?Org_ID=167 ) and has studied the expression of vasopressin and oxytocin in the hypothalamic paraventricular and supraoptic nuclei. Dr. Young's laboratory is currently creating and using knock-out and transgenic mice to study the roles of vasopressin and oxytocin in the brain.
------
------


Line 8: Line 9:


[[Category:CZ Authors|Young, Scott]]
[[Category:CZ Authors|Young, Scott]]
 
[[Category:Inactive CZ Editors|ScottYoung]]
[[Category:CZ Editors|Young, Scott]]
[[Category:Inactive Health Sciences Editors|ScottYoung]]
 
[[Category:Inactive Biology Editors|ScottYoung]]
[[Category:Health Sciences Editors|Young, Scott]]
[[Category:Biology Editors|Young, Scott]]

Latest revision as of 03:41, 22 November 2023


The account of this former contributor was not re-activated after the server upgrade of March 2022.


W. Scott Young, M.D., Ph.D. Dr. Young received his B.A., M.D., and Ph.D from The Johns Hopkins University. The latter degree, obtained under the guidance of Michael Kuhar, described the development of in vitro receptor autoradiography and the first applications of the technique to the localization of neurotranmsitter receptors in human and other animal brains. Dr. Young then completed an internship in internal medicine at the University of Maryland and a residency in neurology at the University of Virginia. He joined the National Institute of Mental Health in 1984 where he is a Senior Investigator ( http://neuroscience.nih.gov/Lab.asp?Org_ID=167 ) and has studied the expression of vasopressin and oxytocin in the hypothalamic paraventricular and supraoptic nuclei. Dr. Young's laboratory is currently creating and using knock-out and transgenic mice to study the roles of vasopressin and oxytocin in the brain.



Citizendium Editor Policy
The Editor Role | Approval Process | Article Deletion Policy

|width=10% align=center style="background:#F5F5F5"|  |}

Welcome, new editor! We're very glad you've joined us. Here are pointers for a quick start. Also, when you get a chance, please read The Editor Role. You can look at Getting Started and our help system for other introductory pages. It is also important, for project-wide matters, to join the Citizendium-L (broadcast) mailing list. Announcements are also available via Twitter. You can test out editing in the sandbox if you'd like. If you need help to get going, the forum is one option. That's also where we discuss policy and proposals. You can ask any administrator for help, too. Just put a note on their "talk" page. Again, welcome and thank you! We appreciate your willingness to share your expertise, and we hope to see your edits on Recent changes soon.

Sarah Tuttle 14:47, 25 November 2006 (CST)